Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

53
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

42
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
42
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

249
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
249
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

60
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
60
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

59
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
59
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

57
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
57

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choline metabolism drives metastasis in BRCA1-deficient ovarian cancers by activating FAM3C.

Nature communications·2026
Same author

The Emerging Roles of Protein Lipidation in Fertility and Reproductive Disorders: Mechanisms and Therapeutic Implications.

Biomolecules·2026
Same author

Coelenterazine alleviates sepsis-associated acute kidney injury by inhibiting ferroptosis via the USP14-NCOA4 pathway.

Translational andrology and urology·2025
Same author

Non canonical BRCA1 promotes cell survival via modulating PARP13-mediated SEC61G mRNA decay.

Oncogenesis·2025
Same author

Natural product Pulsatilla saponin D sensitizes BRCA-proficient ovarian cancers to PARP inhibitors through inhibiting homologous recombination repair.

The Journal of pharmacy and pharmacology·2025
Same author

Phosphorylation of POU3F3 Mediated Nuclear Translocation Promotes Proliferation in Non-Small Cell Lung Cancer through Accelerating ATP5PF Transcription and ATP Production.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same journal

Correction to "Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative Stress".

Oxidative medicine and cellular longevity·2026
Same journal

RETRACTION: Acetaldehyde Induces Neurotoxicity In Vitro via Oxidative Stress- and Ca<sup>2+</sup> Imbalance-Mediated Endoplasmic Reticulum Stress.

Oxidative medicine and cellular longevity·2026
Same journal

Correction to "Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study".

Oxidative medicine and cellular longevity·2026
Same journal

Interplay of Mitochondrial Dynamics, Nutrition, and Vitamins: Evidence From Experimental and Human Studies With Implications for Women's Health.

Oxidative medicine and cellular longevity·2026
Same journal

Correction to "The Protective Effects of Melatonin on Aluminum-Induced Hepatotoxicity and Nephrotoxicity in Rats".

Oxidative medicine and cellular longevity·2026
Same journal

RETRACTION: Plasma Small Extracellular Vesicle-Carried miRNA-501-5p Promotes Vascular Smooth Muscle Cell Phenotypic Modulation-Mediated In-Stent Restenosis.

Oxidative medicine and cellular longevity·2026
See all related articles

Related Experiment Video

Updated: Aug 26, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.9K

Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production.

Xuexia Xie1, Fan Wu1, Jiaxin Tian2

  • 1Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.

Oxidative Medicine and Cellular Longevity
|October 4, 2022
PubMed
Summary
This summary is machine-generated.

Pyrocatechol (PCL) protects against cisplatin-induced kidney injury by preventing oxidative stress and apoptosis. This natural compound activates glutathione peroxidase 4 (GPX4), reducing reactive oxygen species (ROS) and inhibiting harmful JNK/P38 MAPK signaling.

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.2K
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.5K

Related Experiment Videos

Last Updated: Aug 26, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.9K
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.2K
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.5K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • Cisplatin is a vital chemotherapy drug but causes significant nephrotoxicity.
  • Developing effective treatments for cisplatin-induced kidney injury is crucial for patient care.

Purpose of the Study:

  • To identify and evaluate therapeutic agents for mitigating cisplatin-induced nephrotoxicity.
  • To investigate the protective mechanisms of pyrocatechol against cisplatin-induced kidney damage.

Main Methods:

  • In vitro screening of a natural product library to identify protective compounds.
  • In vivo studies administering cisplatin and pyrocatechol to assess kidney injury markers.
  • Mechanistic studies examining the role of oxidative stress, apoptosis, and specific signaling pathways (GPX4, ROS, JNK/P38).

Main Results:

  • Pyrocatechol (PCL) significantly alleviated cisplatin-induced cytotoxicity in vitro.
  • Pyrocatechol treatment reduced inflammatory cell infiltration and apoptosis in vivo.
  • Pyrocatechol activated glutathione peroxidase 4 (GPX4), decreased reactive oxygen species (ROS), and inhibited JNK/P38 MAPK activation.

Conclusions:

  • Pyrocatechol demonstrates significant protective effects against cisplatin-induced kidney injury.
  • The mechanism involves preventing oxidative stress and apoptosis via GPX4 activation and ROS reduction.
  • Pyrocatechol represents a promising therapeutic candidate for managing chemotherapy-related kidney damage.